|
|
.
See Category: Neoplasms
See Header: Malignant neoplasm of overlapping sites of breast, female
ICD-10 (CM) Code and Descriptor
|
C50.812 |
Malignant neoplasm of overlapping sites of left female breast
Diagnosis Valid for Female Patient Only
|
C50812 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 55.87%
|
27.58%
|
8.43%
|
3.44%
|
1.71%
|
1.03%
|
0.60%
|
0.42%
|
0.27%
|
0.18%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C50.812*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
27,504
|
27,656
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
20,839
|
20,842
|
|
80053
|
COMPREHEN METABOLIC PANEL |
20,410
|
20,410
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
16,518
|
16,563
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
11,560
|
11,580
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
7,619
|
8,276
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
4,816
|
10,223
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
4,815
|
7,488
|
|
77387
|
GUIDANCE FOR RADJ TX DLVR |
4,464
|
4,471
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
4,288
|
6,337
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
4,245
|
37,994
|
|
J2405
|
ONDANSETRON HCL INJECTION |
4,046
|
21,909
|
|
77065
|
DX MAMMO INCL CAD UNI |
3,958
|
3,970
|
|
J3010
|
FENTANYL CITRATE INJECTION |
3,905
|
7,092
|
|
88360
|
TUMOR IMMUNOHISTOCHEM/MANUAL |
3,657
|
10,045
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
3,457
|
3,457
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
3,448
|
117,976
|
|
96413
|
CHEMO IV INFUSION 1 HR |
3,396
|
3,396
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
3,355
|
13,596
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
2,874
|
3,052
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C50.812 related to the following DRG Codes:
582-583
597-599
|
